We'd Really Like a Glimpse of the 'Unprecedented Accuracy'

Sep 16, 2008

Technology Review profiles next-gen sequencing company Pacific Biosciences, which has raised $178 million to develop its zero mode waveguide technology. According to the article, the company's got 12 prototype instruments churning out data. And with read lengths targeting thousands of bases, PacBio has its eye on the medical market, where "we'll be able to detect rare mutations with unprecedented accuracy," says CTO Steve Turner.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Keep It (Partly) Virtual

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

For Cross-Protection

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Proteomics of Severity

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

Genome Biology Papers on Regulatory Element, Single-Cell Integration, Sequence Simulation Tools

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.

Menu